Multimodal approach in pain management in pancreatic cancer

Pancreatic cancer is often associated with significant pain, affecting approximately 75% of patients at the time of diagnosis.This type of pain is frequently the first symptom prompting medical consultation, leading to extended diagnostic pathways and ultimately resulting in delayed detection and poorer prognoses due to the formation of metastases.Managing cancer-related pain by integrating many treatment options, such as pharmacological interventions and interventional procedures, is called a multimodal approach and is being discussed in this article.Healthcare providers should coordinate the aforementioned multimodal approaches to ensure cooperation in the process and the patient's safety.Furthermore, hope remains in targeted therapies, which focus on the molecular pathways of pain signaling.There is also an opportunity for more personalized strategies that affect the microenvironment of the cancer.Implementing coordinated multimodal pain management strategies should be a caregiver's priority.